Chrystal U Louis
Merrimack Pharmaceuticals, Cambridge, USA
Biography
Chrystal Louis obtained her MD from Tulane University School of Medicine and her MPH from Tulane University School of Public Health and Tropical Medicine. She completed her pediatric oncology training at the Texas Children’s Cancer and Hematology Centers and Baylor University School of Medicine. As a member of the Center for Cell and Gene Therapy, she became a successful translational researcher in the field of virus-specific and chimeric antigen receptor-specific cellular immunotherapy. Dr Louis joined the Discovery Division of Merrimack Pharmaceuticals in 2014 and is currently the Medical Director and Project Leader of the Istiratumab (MM-141) team.
Abstract
Abstract : A Multi-targeted Approach to Treating Pancreatic Cancer